European Disease Progression Monitor: Edition 5

European Disease Progression Monitor: Edition 5

COVID-19 EU progression monitor

lockdown exit strategies in EU

lockdown transition plan

COVID-19 death rate EU

tracking the pandemic

control phase

French data

U.K. numbers have stabilised

Overview of treatments

Disclaimer

For more information, please visit lek.com/covid19 or fill out this form to get in touch.

Other editions in this series:
European Disease progression monitor: Edition 4

Related Insights

Executive Insights

Life Sciences & Pharma

Transitioning to EU-Wide Health Technology Assessments: Implications for Pharma

April 14, 2025

Life Sciences & Pharma

Unlocking Growth: Singapore's Role in Advancing Life Sciences and Medtech Innovations

March 10, 2025

Video / Webinar

Artificial Intelligence

Look Forward 2025: Proving AI’s Value

January 16, 2025

Executive Insights

Life Sciences & Pharma

Redefining Biopharma R&D Productivity: New Insights and Strategies

January 9, 2025

Executive Insights

Life Sciences & Pharma

In Need of an All-Inclusive Trip: Socio-Demographic Diversity in Psychedelic Research

November 15, 2024

Life Sciences & Pharma

Impact of the US BIOSECURE Act on Biopharmas, Contract Services and Investors

July 2, 2024